CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Aura lays off 20% of workforce, rejigs C-suite amid R&D refocus on eye cancer","$":{"href":"/biotech/aura-lays-20-staff-rejigs-c-suite-amid-rd-refocusing","hreflang":"en"}}]}

Negative
AI Analysis

Summary

Aura Biosciences is laying off 20% of its workforce and restructuring its C-suite under new leadership as it refocuses on ocular oncology research and development.

Importance:3/10
Sentiment:
-0.60
workforce_reductionrestructuringmanagement_changeR&D_refocusocular_oncology
Related Companies

Read the original article

Published by FierceBiotech on August 11, 2026 8:18 AM

Read Original